戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 nd dose), and brain state (i.e., context and concurrent treatments).
2 viduals, there is growing advocacy for their concurrent treatment.
3 site, and having nonadvanced disease without concurrent treatment.
4 and ruxolitinib are not mutually affected by concurrent treatment.
5 n epithelial cells remain unaffected by this concurrent treatment.
6                                              Concurrent treatment appeared to be well tolerated and e
7 and four (2.9%) of 137 patients who received concurrent treatment; by week 24, it had dropped below t
8 tosis assay, whereas the reverse sequence or concurrent treatment did not potentiate apoptosis.
9 f 142 (54.2%, 95% CI 45.7-62.6) who received concurrent treatment (difference 2.3%, 95% CI -9.3 to 13
10 ature of treatment during the run-in period, concurrent treatment during the treatment period, and in
11                                         In a concurrent treatment efficacy study, the target maintena
12 tion and function between patients receiving concurrent treatment for HIV-tuberculosis coinfection an
13  weeks, while those randomly assigned to the concurrent treatment group received paclitaxel and trast
14 18 patients completed at least one course of concurrent treatment (median, two courses; range, one to
15                                              Concurrent treatment of B16F10 tumor-bearing mice with T
16            Here, we test the hypothesis that concurrent treatment of bacteria with antibiotics and aP
17                                     Yet, the concurrent treatment of BD and AUD remains neglected in
18 epression and suggest a new strategy for the concurrent treatment of both conditions via modulation o
19 e the deeper layers of tumor, and to provide concurrent treatment of both the solid tumor and metasta
20                                              Concurrent treatment of cells with arsenite and the radi
21       Clinical practice guidelines recommend concurrent treatment of co-occurring depression and subs
22 requires multiple antihypertensive drugs and concurrent treatment of dyslipidaemia, insulin resistanc
23                                              Concurrent treatment of ketorolac or diclofenac with cid
24 Except for two models of integrated care for concurrent treatment of other conditions, sickle cell di
25 resent study, we have examined the effect of concurrent treatment of OVCA 420 human ovarian cancer ce
26                                              Concurrent treatment of PD-L1 blocking conjugate not onl
27 pically weekly, of integrated treatment (ie, Concurrent Treatment of PTSD and Substance Use Disorders
28 oma-secreted protein-2 (Na-ASP-2), following concurrent treatment of schoolchildren coinfected with S
29        This finding warrants the modeling of concurrent treatment of TB and HIV to potentially reduce
30                                              Concurrent treatment of the RPE65-immunized rats with B.
31                                          The concurrent treatment of tuberculosis and human immunodef
32                          Both sequential and concurrent treatment schedules could induce lethal DNA d
33 was preferred among patients who experienced concurrent treatments, such as HR or CTX.
34 first clinical trial designed to investigate concurrent treatment with a checkpoint inhibitor and con
35      Fifteen (35.7%) patients were receiving concurrent treatment with a second immunosuppressive age
36 substance use disorder, mania, psychosis, or concurrent treatment with a specified list of medication
37                                  We assessed concurrent treatment with abiraterone acetate plus predn
38 were associated with increased likelihood of concurrent treatment with ALND and PMRT.
39 eved in this patient population suggest that concurrent treatment with anticonvulsants and dexamethas
40                          Here, we found that concurrent treatment with both a CDK4/6 inhibitor (CDK4/
41 h and ototoxic injury that can be reduced by concurrent treatment with caspase inhibitors in vitro.
42 erved over the past 3 decades have been from concurrent treatment with chemotherapy and radiotherapy
43 d poorly to cisplatin, but were sensitive to concurrent treatment with cisplatin and EGFR or Stat3 in
44                                              Concurrent treatment with CNi (but not mTORi) reduced in
45 T cells that occurs after ACT was reduced by concurrent treatment with CNi but not by concurrent trea
46  purpose of this study was to assess whether concurrent treatment with GCs (prednisolone) and risedro
47                                              Concurrent treatment with GCs and risedronate prevented
48 ity, blood pressure, and inflammation beyond concurrent treatment with hyperglycaemia drugs or insuli
49 h artery calcification has been inhibited by concurrent treatment with ibandronate or osteoprotegerin
50                                              Concurrent treatment with immune modifier agents and/or
51              Six of the 7 patients underwent concurrent treatment with immune modifier drugs.
52 lity and that this effect may be enhanced by concurrent treatment with IVIG.
53  have utilized extreme hypoxia (0.5% O2) and concurrent treatment with metal carcinogen (nickel) to e
54              The cytotoxicity was blocked by concurrent treatment with MK-801 or by two tetrahydroiso
55          Many patients with epilepsy require concurrent treatment with more than one antiepileptic dr
56  by concurrent treatment with CNi but not by concurrent treatment with mTORi (dose-dependent).
57 We argue that these increases are related to concurrent treatment with neuroleptics rather than a dir
58  of BCNU polymers against malignant gliomas, concurrent treatment with O6-BG may provide an important
59 ready at increased risk of overdose owing to concurrent treatment with opioids and benzodiazepines, o
60 te-to-severe ulcerative colitis who received concurrent treatment with oral corticosteroids or immuno
61                                              Concurrent treatment with PARP and WEE1 inhibitors induc
62                                              Concurrent treatment with PD 98059 and CWF produced addi
63                                    Moreover, concurrent treatment with PDGF and insulin did not dimin
64                                 Accordingly, concurrent treatment with pharmacologic inhibitors of TE
65 received one prior regimen as neoadjuvant or concurrent treatment with radiation.
66 cDDP-mediated tumor cell kill as compared to concurrent treatment with Ro23-7553 and cDDP or cDDP alo
67                        In the present study, concurrent treatment with robotic step training and a se
68 of MEK inhibitor-insensitive CRC cell lines, concurrent treatment with selumetinib did not provide ad
69                     Rescue experiments using concurrent treatment with small interfering RNA or inhib
70                                  Conversely, concurrent treatment with SN-38 and UCN-01 resulted in S
71 ering RNA-mediated knockdown of RelA/p65, or concurrent treatment with SP600125, indicating a require
72                                              Concurrent treatment with temozolomide and radiotherapy
73 ncrease in bone resorption activity and that concurrent treatment with the 40-mg dose of SB 242784 re
74  both of these effects were fully blocked by concurrent treatment with the CRF receptor antagonist D-
75                                    In vitro, concurrent treatment with the estrogen receptor antagoni
76 obilization of TRPC6 channels was blocked by concurrent treatment with the NMDA antagonist MK-801 and
77 enhances autophagic flux and dependency, and concurrent treatment with the nonspecific autophagy inhi
78 TMS and in Apoe(-/-)/Cyp1b1(-/-) mice and by concurrent treatment with the superoxide scavenger 4-hyd
79  degree of secondary hyperparathyroidism and concurrent treatment with vitamin D.